Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantTAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
CAPSULE
ORAL
Medical Information
L01EK04
Manufacturer Information
TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
STA Pharmaceutical Switzerland SA
Active Ingredients
Documents
Package Inserts
Fruzaqla Capsule PI.pdf
Approved: October 17, 2024